Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

A screen grab taken from a video issued by Britain's Oxford University shows a person being injected as part of the first human trials in the United Kingdom to test a potential COVID-19 vaccine.

Pool/The Canadian Press

While the government spends hundreds of millions of dollars to develop and test potential vaccines for COVID-19, experts say mandatory vaccination is unlikely given the difficult practical and ethical problems that would entail.

“A vaccine will be extremely important to getting back to normal,” Prime Minister Justin Trudeau said Tuesday, adding that effective treatment could help us get there too.

A recent poll conducted by Leger and the Association for Canadian Studies found 60 per cent of respondents believe people should be required to get the vaccine once it’s ready, although that is likely to be many months away.

Story continues below advertisement

It’s understandable people feel that way, said vaccine expert Dr. Noni MacDonald, but mandatory vaccines are a complicated proposition.

There are no truly mandatory vaccines in Canada. While provinces like Ontario and New Brunswick require children to be vaccinated in order to attend school, there are exemptions for medical and ideological reasons.

For adults, the only Canadian precedent for mandatory vaccines is for medical workers who must be immunized against certain diseases to protect themselves and their patients, MacDonald said.

“What’s your consequences for not doing it if you make it mandatory?” said MacDonald, a professor with the faculty of medicine at Dalhousie University. “What’s your penalty? Or what’s your incentive?”

Those questions are more complex than they appear, and can lead policy-makers down a rabbit hole.

Australia tried to convince parents to immunize their children by making certain tax benefits contingent on those vaccinations, MacDonald said.

“The group that it really harmed was the very low-income people who had to take time off work to get their child immunized,” she said. “And they got a double whammy. They not only didn’t get their child immunized, which meant they couldn’t go to daycare or go to school, but they also didn’t get the child tax credit.”

Story continues below advertisement

Ethically speaking, the government would have to make sure not to unduly penalize people who don’t get the vaccine.

Policy-makers also have to worry about a backlash, said Ubaka Ogbogu, an associate professor with the University of Alberta who specializes in law and bioethics.

“The reason why we should probably not raise the question of mandatory vaccination in relation to COVID-19 is because it’s deeply controversial,” Ogbogu said.

There is usually vehement opposition to mandatory vaccination, at least by small but vocal groups who worry about the safety of vaccines and government infringement on their liberties.

Those people are likely to be even more concerned about a rapidly developed vaccine, he said.

“The last thing you want is for (a vaccine) to become available, and then we spend a lot of time fighting over whether it should be mandatory or not, when I think people are going to want it,” he said. “I think what we’re going to have is the opposite issue.”

Story continues below advertisement

The question of whether to make the vaccine mandatory assumes there will be enough to go around, which both experts agree is doubtful.

It’s difficult to know what the uptake in an eventual vaccine will be, said chief public health officer Dr. Theresa Tam.

“Sometimes it’s quite an emotional reaction,” she said Saturday.

“I recall in the last pandemic when you’d get an increase in deaths, for example, people will suddenly want to take up the vaccine very fast when you don’t have enough to go around.”

The more likely ethical quandary for policy-makers will involve figuring out how to distribute a limited supply of the vaccine in a way that is fair and effective.

That will depend on how knowledge of the vaccine and the disease develops.

Story continues below advertisement

Influenza, for example, spreads rampantly among kids who are in school so it’s important to boost their immunity. But it’s not clear if the same is true of COVID-19, MacDonald said. It may be that health-care workers should be the first to receive the vaccine, or people who work in long-term care homes.

To make matters more complicated, with several vaccines in development the successful candidates may be more effective in some populations than others.

Those are all factors that will have to be sorted out as the government works toward rolling out a vaccine in Canada.

The federal and provincial governments are going to have to make “extremely important decisions,” about how to achieve the optimal level of vaccination, Trudeau said Tuesday, and those decisions will be informed by research.

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies